Form 8-K - Current report:
SEC Accession No. 0001558370-24-004785
Filing Date
2024-04-05
Accepted
2024-04-05 16:15:18
Documents
15
Period of Report
2024-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K elev-20240403x8k.htm   iXBRL 8-K 32942
  Complete submission text file 0001558370-24-004785.txt   193321

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20240403.xsd EX-101.SCH 4227
3 EX-101.DEF elev-20240403_def.xml EX-101.DEF 2818
4 EX-101.LAB elev-20240403_lab.xml EX-101.LAB 12905
5 EX-101.PRE elev-20240403_pre.xml EX-101.PRE 12298
18 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240403x8k_htm.xml XML 4998
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 24826695
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)